Effects of Flaxseed Lignan Secoisolariciresinol Diglucosideon Preneoplastic Biomarkers of Cancer Progression in a Model of Simultaneous Breast and Ovarian Cancer Development

Nutrition and Cancer

Volumn 67, Issue 5, 2015, Pages 857-864

  Delman, Devora M ^a   Fabian, Carol J ^a   Kimler, Bruce F ^a   Yeh, Henry ^b   Petroff, Brian K ^a,c  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTANEDIOL; GLUCOSIDE; KI 67 ANTIGEN; PHYTOESTROGEN; SECOISOLARICIRESINOL DIGLUCOSIDE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TUMOR MARKER;

ANIMAL; AUGUST COPENHAGEN IRISH RAT; BREAST NEOPLASMS; CELL ADHESION; CHEMICALLY INDUCED; CHEMISTRY; DISEASE COURSE; DISEASE MODEL; FEMALE; FLAX; METABOLISM; OVARIAN NEOPLASMS; PATHOLOGY; PLANT SEED; PRECANCER; PRECLINICAL STUDY; RAT;

ANIMALS; BIOMARKERS, TUMOR; BREAST NEOPLASMS; BUTYLENE GLYCOLS; CELL ADHESION; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DRUG EVALUATION, PRECLINICAL; ESTROGEN RECEPTOR MODULATORS; FEMALE; FLAX; GLUCOSIDES; KI-67 ANTIGEN; OVARIAN NEOPLASMS; PHYTOESTROGENS; PRECANCEROUS CONDITIONS; RATS; RATS, INBRED ACI; SEEDS;

EID: 84934443844     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2015.1042549     Document Type: Article

References (34)

1. Lowcock EC, Cotterchio M, and Boucher BA: Consumption of flaxseed, a rich source of lignans, is associated with reduced breast cancer risk. Cancer Causes Control 24, 813-816, 2013. doi: 10.1007/s10552-013-0155-7
2. Lindahl G, Saarinen N, Abrahamsson A, and Dabrosin C: Tamoxifen, flaxseed, and the lignan enterolactone increase stroma-and cancer cellderived IL-1Ra and decrease tumor angiogenesis in estrogen-dependent breast cancer. Cancer Res 71, 51-60, 2011. doi:10.1158/0008-5472. CAN-10-2289
3. Nesbitt PD, Lam Y, and Thompson LU: Human metabolism of mammalian lignan precursors in raw and processed flaxseed. Am J Clin Nutr 69, 549-555, 1999.
4. Bergman Jungestrom M, Thompson LU, and Dabrosin C: Flaxseed and its lignans inhibit estradiol-induced growth, angiogenesis, and secretion of vascular endothelial growth factor in human breast cancer xenografts in vivo. Clin Cancer Res 13, 1061-1067, 2007. doi:10.1158/1078-0432. CCR-06-1651
5. Thompson LU, Rickard SE, Orcheson LJ, and Seidl MM: Flaxseed and its lignan and oil components reduce mammary tumor growth at a late stage of carcinogenesis. Carcinogenesis 17, 1373-1376, 1996. doi:10.1093/carcin/17.6.1373
6. Ansenberger K, Richards C, Zhuge Y, Barua A, Bahr JM, et al.: Decreased severity of ovarian cancer and increased survival in hens fed a flaxseed-enriched diet for 1 year. Gynecol Oncol 117, 341-347, 2010. doi:10.1016/j.ygyno.2010.01.021
7. Inal MM: Ovarian cysts in tamoxifen-treated women with breast cancer. European journal of obstetrics & gynecology and reproductive biology 120, 104-106, 2005. doi: 10.1016/j.ejogrb.2004.09.006
8. Petroff BK: A case for combined ovarian and breast cancer prevention. Medical hypotheses 79, 549-51, 2012. doi: 10.1016/j.mehy.2012.07.018
9. Kang S, Lee A, Park YS, Lee SC, Park SY, et al.: Alteration in lipid and protein profiles of ovarian cancer: similarity to breast cancer. Int J Gynecol Cancer 21, 1566-1572, 2011. doi:10.1097/IGC.0b013e318226c5f5
10. Braem MG, Onland-Moret NC, van den Brandt PA, Goldbohm RA, Peeters PH, et al.: Reproductive and hormonal factors in association with ovarian cancer in the Netherlands cohort study. Am J Epidemiol 172, 1181-1189, 2010. doi:10.1093/aje/kwq264
11. Ting AY, Kimler BF, Fabian CJ, and Petroff BK: Characterization of a preclinical model of simultaneous breast and ovarian cancer progression. Carcinogenesis 28, 130-135, 2007. doi:10.1093/carcin/bgl140
12. Ting AY, Kimler BF, Fabian CJ, Petroff BK: Tamoxifen prevents premalignant changes of breast, but not ovarian, cancer in rats at high risk for both diseases. Cancer Prev Res (Phila) 1, 546-553, 2008. doi: 10.1158/1940-6207.capr-08-0015
13. Fabian CJ, Kimler BF, Zalles CM, Klemp JR, Petroff BK, et al.: Reduction in Ki-67 in benign breast tissue of high-risk women with the lignan secoisolariciresinol diglycoside. Cancer Prev Res (Phila) 3, 1342-1350, 2010. doi:10.1158/1940-6207.capr-10-0022
14. Anzalone CR, Hong LS, Lu JK, and LaPolt PS: Influences of age and ovarian follicular reserve on estrous cycle patterns, ovulation, and hormone secretion in the Long-Evans rat. Biol Reprod 64, 1056-1062, 2001.
15. Chatterjee A and Greenwald GS: The long-term effects of unilateral ovariectomy of the cycling hamster and rat. Biol Reprod 7, 238-246, 1972.
16. Riman T, Nilsson S, and Persson IR: Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies. Acta Obstet Gynecol Scand 83, 783-795, 2004. doi:10.1111/j.0001-6349.2004.00550.x
17. Stewart SL, Querec TD, Ochman AR, Gruver BN, Bao R, et al.: Characterization of a carcinogenesis rat model of ovarian preneoplasia and neoplasia. Cancer Res 64, 8177-8183, 2004. doi:10.1158/0008-5472.CAN-04-1702
18. Li SA, Weroha SJ, Tawfik O, and Li JJ: Prevention of solely estrogen-induced mammary tumors in female aci rats by tamoxifen: evidence for estrogen receptor mediation. J Endocrinol 175, 297-305, 2002.
19. National Research Council. Nutrient Requirements of Laboratory Animals. Washington, DC: National Academy Press, 1995.
20. Setchell KD, Childress C, Zimmer-Nechemias L, and Cai J: Method for measurement of dietary secoisolariciresinol using HPLC with multichannel electrochemical detection. J Med Food 2, 193-198, 1999. doi:10.1089/jmf.1999.2.193
21. Setchell KD, Lawson AM, McLaughlin LM, Patel S, Kirk DN, et al.: Measurement of enterolactone and enterodiol, the first mammalian lignans, using stable isotope dilution and gas chromatography mass spectrometry. Biomed Mass Spectrom 10, 227-235, 1983. doi:10.1002/bms.1200100321
22. Crist KA, Zhang Z, You M, Gunning WT, Conran PB, et al.: Characterization of rat ovarian adenocarcinomas developed in response to direct instillation of 7,12-dimethylbenz[a]anthracene (DMBA) coated suture. Carcinogenesis 26, 951-957, 2005. doi:10.1093/carcin/bgi039
23. Russo J and Russo IH: Atlas and histologic classification of tumors of the rat mammary gland. J Mammary Gland Biol Neoplasia 5, 187-200, 2000.
24. Aberg UW, Saarinen N, Abrahamsson A, Nurmi T, Engblom S, et al.: Tamoxifen and flaxseed alter angiogenesis regulators in normal human breast tissue in vivo. PLoS One 6, e25720, 2011. doi:10.1371/journal. pone.0025720
25. Chen J, Wang L, and Thompson LU: Flaxseed and its components reduce metastasis after surgical excision of solid human breast tumor in nude mice. Cancer Lett 234, 168-175, 2006. doi:10.1016/j. canlet.2005.03.056
26. Thompson LU, Chen JM, Li T, Strasser-Weippl K, and Goss PE: Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer. Clin Cancer Res 11, 3828-3835, 2005. doi: 10.1158/1078-0432.ccr-04-2326
27. Power KA, Chen JM, Saarinen NM, and Thompson LU: Changes in biomarkers of estrogen receptor and growth factor signaling pathways in MCF-7 tumors after short-and long-term treatment with soy and flaxseed. J Steroid Biochem Mol Biol 112, 13-19, 2008. doi:10.1016/j. jsbmb.2008.07.003
28. Rickard SE, Yuan YV, Chen J, Thompson LU: Dose effects of flaxseed and its lignan on N-methyl-N-nitrosourea-induced mammary tumorigenesis in rats. Nutr Cancer 35, 50-57, 1999. doi:10.1207/s1532791450-57
29. Thompson LU, Seidl MM, Rickard SE, Orcheson LJ, and Fong HH: Antitumorigenic effect of a mammalian lignan precursor from flaxseed. Nutr Cancer 26, 159-165, 1996. doi:10.1080/01635589609514472
30. Tou JC and Thompson LU: Exposure to flaxseed or its lignan component during different developmental stages influences rat mammary gland structures. Carcinogenesis 20, 1831-1835, 1999.
31. Prasad K: Antioxidant activity of secoisolariciresinol diglucoside-derived metabolites, secoisolariciresinol, enterodiol, and enterolactone. Int J Angiol 9, 220-225, 2000
32. Lee J and Cho K: Flaxseed sprouts induce apoptosis and inhibit growth in MCF-7 and MDA-MB-231 human breast cancer cells. In Vitro Cell Dev Biol Anim 48, 244-250, 2012. doi:10.1007/s11626-012-9492-1
33. Carreau C, Flouriot G, Bennetau-Pelissero C, and Potier M: Enterodiol and enterolactone, two major diet-derived polyphenol metabolites have different impact on ERalpha transcriptional activation in human breast cancer cells. J Steroid Biochem Mol Biol 110, 176-185, 2008. doi:10.1016/j.jsbmb.2008.03.032
34. Breier G: Endothelial cadherins in cancer. Cell and tissue research 355, 523-527, 2014. doi:10.1007/s00441-014-1851-7